News
-
-
PRESS RELEASE
Affluent Medical : Affluent Medical extends the horizon of its cash position to end-2025 with support from its key shareholders
Affluent Medical extends cash position to end-2025 with €5.4 million in convertible bonds from key shareholders to support clinical and regulatory developments -
-
-
PRESS RELEASE
Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and receives approval to initiate pivotal phase of its clinical trial .
Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and approval for pivotal clinical trial phase -
-
PRESS RELEASE
Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and receives approval to initiate pivotal phase of its clinical trial
Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and approval for pivotal clinical trial phase to reduce urinary leakage by 87% -
-
-
PRESS RELEASE
Affluent Medical : 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap
Affluent Medical reached major new milestones in executing its clinical roadmap in 2024, including transformative agreements and positive FDA feedback. Financial results show progress and strategic appointments
